Rising costs for medical devices remain a big headache for health plans and their sponsors, as well as patients who will have to share the burden in some way. Although lately the growth of expenditures may have slowed a bit, the driver has not been better prices, but the postponing (or avoiding) of elective procedures in the light of the economic troubles, as well as some payer pushback based on studies that suggested that a significant number of implants may have questionable medical benefit.
I am planning to provide some thoughts about this question over the coming days.
He is Managing Principal, Healthcare Insurers and Payers at ZS Associates.
This post is the author’s own and does not necessarily represent ZS Associates’ positions, strategies or opinions.